Cytodyn's 12/7/2022 8-k Investor Oncology prese
Post# of 155347
(Total Views: 615)
Posted On: 07/05/2025 11:25:02 PM
Cytodyn's 12/7/2022 8-k
Investor Oncology presentation by Dr. Gluk
Sidebar says Monotherapy.
NCT04504942
Solid Tumor Basket
Shows @ 525 mg
__
His Pg 69 is the blue graph showing which tumors are & are not responsive to todays treatments with % ratings
Now relevant to double look @ that blue graph title:
Three Catagories of Response to Anti-PD-1/PD-L1
__
Zero % response:
Glioblastoma
Pancreatic
CRC-MSS
Prostate
Breast @ 12% response
___
The trial, his presentation & Barcelona poster, should all confirm:
*No past CRC/ICI dosed
*525 mg doubled the mOS
Which in of itsself, is phenominal
700 mg & ICI regiment coming front-n-center
Investor Oncology presentation by Dr. Gluk
Sidebar says Monotherapy.
NCT04504942
Solid Tumor Basket
Shows @ 525 mg
__
His Pg 69 is the blue graph showing which tumors are & are not responsive to todays treatments with % ratings
Now relevant to double look @ that blue graph title:
Three Catagories of Response to Anti-PD-1/PD-L1
__
Zero % response:
Glioblastoma
Pancreatic
CRC-MSS
Prostate
Breast @ 12% response
___
The trial, his presentation & Barcelona poster, should all confirm:
*No past CRC/ICI dosed
*525 mg doubled the mOS
Which in of itsself, is phenominal
700 mg & ICI regiment coming front-n-center
(9)
(0)